Clinical Trials Browser

Enrolling by invitation × Cholangiocarcinoma × 90 days × Clear all

NCT06474091 2026-03-16

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

Enrolling by invitation

Gastrointestinal

Cholangiocarcinoma

NCT06506955 2026-03-11

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Phase 2/3 Enrolling by invitation

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT05404503 2026-01-06

QuiCo

Enrolling by invitation

Gastrointestinal

Choledochal Cyst, Cholangiocarcinoma